Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca
Genebra; World Health Organization; feb. 10, 2021. 7 p.
Non-conventional
en En
| ColecionaSUS
| ID: biblio-1151150
Biblioteca responsable:
BR1.1
ABSTRACT
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its extraordinary meeting on 8 February 2021.
Texto completo:
1
Colección:
06-national
/
BR
Base de datos:
ColecionaSUS
Asunto principal:
Neumonía Viral
/
Vacunas Virales
/
Infecciones por Coronavirus
/
Pandemias
/
Betacoronavirus
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Non-conventional
Pais de publicación:
Suiza